EIF Fundamental Analysis - MEDNATION AG

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to EIF. EIF was compared to 28 industry peers in the Health Care Providers & Services industry. The financial health of EIF is average, but there are quite some concerns on its profitability. EIF does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

EIF had positive earnings in the past year.

In the past year EIF had a positive cash flow from operations.

In multiple years EIF reported negative net income over the last 5 years.

In the past 5 years EIF always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.29%, EIF is doing worse than 71.43% of the companies in the same industry.

EIF has a worse Return On Equity (0.90%) than 75.00% of its industry peers.

EIF has a worse Return On Invested Capital (2.01%) than 75.00% of its industry peers.

The Average Return On Invested Capital over the past 3 years for EIF is below the industry average of 6.48%.

The 3 year average ROIC (1.75%) for EIF is below the current ROIC(2.01%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	0.29%
ROE	0.9%
ROIC	2.01%

ROA(3y)-0.31%

ROA(5y)-1.7%

ROE(3y)-5.18%

ROE(5y)-13.87%

ROIC(3y)1.75%

ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 0.21%, EIF is not doing good in the industry: 75.00% of the companies in the same industry are doing better.

The Operating Margin of EIF (2.95%) is worse than 67.86% of its industry peers.

In the last couple of years the Operating Margin of EIF has declined.

Looking at the Gross Margin, with a value of 90.58%, EIF belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.

EIF's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	2.95%
PM (TTM)	0.21%
GM	90.58%

OM growth 3YN/A

OM growth 5Y-8.88%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.52%

GM growth 5Y-0.44%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

EIF has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

The number of shares outstanding for EIF has been reduced compared to 1 year ago.

Compared to 5 years ago, EIF has less shares outstanding

Compared to 1 year ago, EIF has an improved debt to assets ratio.

2.2 Solvency

EIF has an Altman-Z score of 1.77. This is a bad value and indicates that EIF is not financially healthy and even has some risk of bankruptcy.

EIF has a Altman-Z score of 1.77. This is comparable to the rest of the industry: EIF outperforms 50.00% of its industry peers.

The Debt to FCF ratio of EIF is 8.55, which is on the high side as it means it would take EIF, 8.55 years of fcf income to pay off all of its debts.

With a Debt to FCF ratio value of 8.55, EIF perfoms like the industry average, outperforming 57.14% of the companies in the same industry.

EIF has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 1.06, EIF is not doing good in the industry: 60.71% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	1.06
Debt/FCF	8.55
Altman-Z	1.77

ROIC/WACC0.55

WACC3.68%

2.3 Liquidity

A Current Ratio of 1.57 indicates that EIF should not have too much problems paying its short term obligations.

EIF has a better Current ratio (1.57) than 71.43% of its industry peers.

EIF has a Quick Ratio of 1.38. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.

EIF has a Quick ratio of 1.38. This is in the better half of the industry: EIF outperforms 78.57% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.57
Quick Ratio	1.38

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for EIF have decreased strongly by -85.94% in the last year.

The Revenue has been growing slightly by 7.56% in the past year.

The Revenue has been growing slightly by 0.13% on average over the past years.

EPS 1Y (TTM)-85.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-122.57%

Revenue 1Y (TTM)7.56%

Revenue growth 3Y10.85%

Revenue growth 5Y0.13%

Sales Q2Q%3.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 93.50, which means the current valuation is very expensive for EIF.

71.43% of the companies in the same industry are cheaper than EIF, based on the Price/Earnings ratio.

EIF is valuated expensively when we compare the Price/Earnings ratio to 26.90, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	93.5
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EIF is valued cheaply inside the industry as 89.29% of the companies are valued more expensively.

EIF's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EIF is cheaper than 82.14% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	4.05
EV/EBITDA	5.5

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

EIF does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MEDNATION AG

FRA:EIF (9/2/2025, 7:00:00 PM)

1.87

+0.02 (+1.08%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)09-30 2024-09-30

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners25.13%

Ins Owner ChangeN/A

Market Cap5.83M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	93.5
Fwd PE	N/A
P/S	0.12
P/FCF	4.05
P/OCF	2.52
P/B	0.5
P/tB	0.5
EV/EBITDA	5.5

EPS(TTM)0.02

EY1.07%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.46

FCFY24.72%

OCF(TTM)0.74

OCFY39.64%

SpS15.63

BVpS3.71

TBVpS3.7

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	0.29%
ROE	0.9%
ROCE	4.73%
ROIC	2.01%
ROICexc	2.23%
ROICexgc	2.23%
OM	2.95%
PM (TTM)	0.21%
GM	90.58%
FCFM	2.96%

ROA(3y)-0.31%

ROA(5y)-1.7%

ROE(3y)-5.18%

ROE(5y)-13.87%

ROIC(3y)1.75%

ROIC(5y)N/A

ROICexc(3y)1.97%

ROICexc(5y)N/A

ROICexgc(3y)1.97%

ROICexgc(5y)N/A

ROCE(3y)4.15%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5Y6.43%

ROICexc growth 3YN/A

ROICexc growth 5Y6.41%

OM growth 3YN/A

OM growth 5Y-8.88%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.52%

GM growth 5Y-0.44%

F-Score7

Asset Turnover1.35

Health

		Industry Rank	Sector Rank
Debt/Equity	1.06
Debt/FCF	8.55
Debt/EBITDA	4.48
Cap/Depr	66.39%
Cap/Sales	1.79%
Interest Coverage	2.13
Cash Conversion	84.1%
Profit Quality	1378.59%
Current Ratio	1.57
Quick Ratio	1.38
Altman-Z	1.77

F-Score7

WACC3.68%

ROIC/WACC0.55

Cap/Depr(3y)35.94%

Cap/Depr(5y)25.78%

Cap/Sales(3y)1.15%

Cap/Sales(5y)1.49%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-85.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-122.57%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)7.56%

Revenue growth 3Y10.85%

Revenue growth 5Y0.13%

Sales Q2Q%3.33%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-20.59%

EBIT growth 3YN/A

EBIT growth 5Y-8.76%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y134.09%

FCF growth 3Y-18.54%

FCF growth 5Y-3.22%

OCF growth 1Y133.4%

OCF growth 3Y-13.99%

OCF growth 5Y-5.06%

MEDNATION AG (EIF.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens